Nutritional Markers in Normal and Hyperemesis Pregnancies
NCT ID: NCT02619188
Last Updated: 2016-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2015-09-30
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pregnancy Specific Nausea Questionnaire (PUQE) Translated and Tested in Norwegian
NCT01836835
Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment
NCT04785911
Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum
NCT06581796
Anxiety in Relation to Nausea and Vomiting in Pregnancy
NCT06059794
HealthyPregnancy - Digital Support for Pregnant Women with a BMI At 25 or Above (BMI≥25)
NCT06734910
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will compare clinical nutritional parameters (weight gain/weight loss) with rate of nausea (PUQE-questionnaire), self-reported nutritional intake form and biochemical measurements (prealbumin) in women admitted to hospital with hyperemesis gravidarum and healthy pregnant women.
For hyperemesis patients measurements will be repeated at discharge.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyperemesis gravidarum
Hyperemesis gravidarum patients admitted to hospital PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis), Intervention at discharge : PUQE-form, Nutritional form and Blood sampling
PUQE-form inclusion
PUQE-form encompassing last 24 hours completion
Nutritional form inclusion
Food-list form encompassing last 24 hours completion
Blood sampling inclusion
Measurement of biochemical nutrition marker(s); Prealbumin
Intervention at discharge
PUQE-form, nutritional form and Blood sampling
Control: Healthy pregnant women
Outpatients NOT subjected to severe nausea and emesis (PUQE-score \<13). PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis).
PUQE-form inclusion
PUQE-form encompassing last 24 hours completion
Nutritional form inclusion
Food-list form encompassing last 24 hours completion
Blood sampling inclusion
Measurement of biochemical nutrition marker(s); Prealbumin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PUQE-form inclusion
PUQE-form encompassing last 24 hours completion
Nutritional form inclusion
Food-list form encompassing last 24 hours completion
Blood sampling inclusion
Measurement of biochemical nutrition marker(s); Prealbumin
Intervention at discharge
PUQE-form, nutritional form and Blood sampling
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to hospital for hyperemesis gravidarum (HG group) with nausea and vomiting in pregnancy with at least two of following criteria; weight loss, dehydration, fluid-/electrolyte disturbances, ketonuria
Exclusion Criteria
* Unable to understand Norwegian
* PUQE-score \>= 13 (control group)
* Nausea an vomiting in pregnancy caused by other conditions than Hyperemesis gravidarum
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bergen
OTHER
Haukeland University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jone Trovik, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Senior consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital
Bergen, Hordaland, Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Birkeland E, Stokke G, Tangvik RJ, Torkildsen EA, Boateng J, Wollen AL, Albrechtsen S, Flaatten H, Trovik J. Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study. PLoS One. 2015 Apr 1;10(4):e0119962. doi: 10.1371/journal.pone.0119962. eCollection 2015.
Stokke G, Gjelsvik BL, Flaatten KT, Birkeland E, Flaatten H, Trovik J. Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: a 10-year retrospective cohort study. Acta Obstet Gynecol Scand. 2015 Apr;94(4):359-67. doi: 10.1111/aogs.12578. Epub 2015 Feb 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/894
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.